Skip to main content
. 2015 Oct 27;5:242. doi: 10.3389/fonc.2015.00242

Figure 3.

Figure 3

Stability of EFT makers in OX40L transgenic EFT cells. Expression of the indicated markers was assessed by RT-PCR in cells without transfection (1), after transfection with empty pIRES-eGFP vector (2), or after transfection with OX40L in vector pIRES-eGFP (3). Actin beta (ACTB) served as housekeeping control. The neomycin-resistance cassette (NeoR) and enhanced green fluorescent protein (eGFP) served as markers for the presence of the vector in the cells. Transfected and wild-type Ewing sarcoma cells expressed the Ewing sarcoma-specific EWS-FLI1 oncofusion transcripts as well as the Ewing sarcoma-associated factors lipase I (LIPI), lipase H (LIPH), CD99, cyclin D1 (CCND1), janus kinase 1 (JAK1), and cytochrome P450 family member 26B1 (CYP26B1).